Here is the ASCO Kevetrin Presentation Info :

Developmental Therapeutics - Clinical Pharmacology and Experimental Therapeutics

Mon, Jun 3
8:00 AM - 11:45 AM
S Hall A2 (Location)

Abstract #TPS2627 A phase I, dose-escalation, safety, pharmacokinetic, pharmacodynamic study of thioureidobutyronitrile, a novel p53 targeted therapy, in patients with advanced solid tumors .
Geoffrey Shapiro, MD, PhD

The floor plan, where Dr. Shapiro will be in the green General Poster area: (glad its by the food court, lol)

http://events.jspargo.com/asco13/Public/Floor...;Mapid=232

And finally, some virtual access options for anyone not attending ASCO. Perhaps CTIX will get some airplay here?

http://chicago2013.asco.org/virtual-access-meeting


Also, just a liting of Dr. Shapiro's past ASCO presentations, he is a seasoned veteran at ASCO :
http://meetinglibrary.asco.org/search/site/?t...3AAbstract